中升(00881.HK)總代價13億美元購仁孚中國 其中4億美元代價配股支付
中升(00881.HK)公佈,向主要股東之一JSH旗下Jardine Motors收購仁孚中國,仁孚中國爲梅賽德斯-奔馳於華南及華西最大經銷商網絡之一。
收購代價爲13億美元,並可進行完成調整。其中9億美元以現金支付,來自中升內部資源及銀行融資。其餘部份將發行股份支付,每股代價股份發行價63.3964港元,較上一個交易日收市價折讓2.4%。以4億美元代價計,預計將發行4,897.5萬股,相當於擴大後股本2.07%。
由於賣方Jardine Motors爲怡和之附屬公司,JSH(交易前持有中升19.58%)爲怡和之全資附屬公司,完成上述交易、緊隨配發及發行代價股份後,怡和對中升的持股量將增至共21.25%,屬關連交易。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.